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Abstract The serotonin1A receptor is the most extensively studied member of the family of
seven transmembrane domain G-protein coupled serotonin receptors. Since a large portion of
such transmembrane receptors remains in contact with the membrane lipid environment, lipid–
protein interactions assume importance in the structure-function analysis of such receptors. We
have earlier reported the requirement of cholesterol for serotonin1A receptor function in native
hippocampal membranes by specific depletion of cholesterol using methyl- b-cyclodextrin. In
this paper, we monitored the serotonin1A receptor function in membranes that are enriched in
cholesterol using a complex prepared from cholesterol and methyl-b-cyclodextrin. Our results
indicate that ligand binding and receptor/G-protein interaction of the serotonin1A receptor do
not exhibit significant difference in native and cholesterol-enriched hippocampal membranes
indicating that further enrichment of cholesterol has little functional consequence on the
serotonin1A receptor function. These results therefore provide new information on the effect of
cholesterol enrichment on the hippocampal serotonin1A receptor function.
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5-HT1A receptor 5-hydroxytryptamine-1A receptor
8-OH-DPAT 8-hydroxy-2(di-N-propylamino) tetralin
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p-MPPI 4-(2¢-methoxy)-phenyl-1-[2¢-(N-2¢¢-pyridinyl)-p-iodobenzamido]
ethyl-piperazine
PMSF phenylmethylsulfonyl fluoride
p-MPPF 4-(2¢-methoxy)-phenyl-1-[2¢-(N-2¢¢-pyridinyl)-p-fluorobenzamido]
ethyl-piperazine
Introduction
Lipid–protein interactions assume importance in the structure-function analysis of membrane
proteins (Huber et al. 2004). Since a large portion of transmembrane receptors remains in
contact with the membrane lipid environment, there exists the possibility that the membrane
could be an important modulator of receptor structure and function (Lee 2004). Cholesterol is
an essential component of eukaryotic membranes and is often found distributed non-randomly
in domains in biological and model membranes (Schroeder et al. 1995; Mukherjee and
Maxfield 2004). The effect of cholesterol on the structure and function of integral membrane
proteins has been a subject of intense investigation (Burger et al. 2000). Cholesterol has been
reported to modulate membrane protein function either through a specific molecular interac-
tion with such proteins (Gimpl et al. 2002), or due to alterations in the membrane physical
properties induced by the presence of cholesterol (Ohvo-Rekila et al. 2002; Lee 2004), or due
to a combination of both factors. In view of the importance of cholesterol in the organization,
dynamics and function of eukaryotic membranes (Schroeder et al. 1995; Mukherjee and
Maxfield 2004), which regulate membrane protein function (Burger et al. 2000), the interaction
of cholesterol with membrane proteins represents an important determinant in the functional
studies of such proteins.
Serotonergic signaling plays a crucial role in the generation and modulation of various
cognitive and behavioral functions such as sleep, mood, pain, addiction, locomotion, sexual
activity, depression, anxiety, alcohol abuse, aggression and learning (Artigas et al. 1996;
Ramboz et al. 1998; Rocha et al. 1998; Meneses 1999). Disruptions in serotonergic systems
have been implicated in the etiology of mental disorders such as schizophrenia, migraine,
depression, suicidal behavior, infantile autism, eating disorders, and obsessive compulsive
disorder (Ramboz et al. 1998; Heisler et al. 1998; Parks et al. 1998; Sarnyai et al. 2000).
Serotonergic signaling is initiated by the binding of serotonin to distinct cell surface receptors
which have been classified into many groups (Hoyer et al. 2002). Among the 14 subtypes of
serotonin receptors, the G-protein coupled serotonin1A (5-HT1A) receptor subtype is the most
extensively studied for a number of reasons that include its importance in neuronal physiology
and the early availability of ligands that bind the receptor with high affinity and specificity that
has resulted in extensive pharmacological characterization of this receptor (Pucadyil et al.
2005a). The 5-HT1A receptor has been implicated in neural development (del Olmo et al. 1998;
Gross et al. 2002) and protection of stressed neuronal cells undergoing degeneration and
apoptosis (Singh et al. 1996). Importantly, antagonists of the 5-HT1A receptor represent a
major class of molecules with potential therapeutic effects in anxiety- or stress-related dis-
orders (Griebel 1999). Furthermore, 5-HT1A receptor levels have been shown to be increased
in schizophrenia (Sumiyoshi et al. 1996) and major depression (Fajardo et al. 2003). Inter-
estingly, several epidemiological studies have correlated altered serum cholesterol concen-
tration with major depressive disorder (MDD)-like symptoms and the prevalence of suicide in
humans (Papakostas et al. 2004). Such behavioral symptoms have earlier been partially
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attributed to disruptions in serotonergic signaling as a result of an alteration in serotonin
receptor function (Engelberg 1992; Vevera et al. 2005). A more detailed analysis of the effects
of modulating membrane cholesterol content on the function of such receptors could provide
insight into the etiology of such disorders.
The role of cholesterol in modulating the hippocampal 5-HT1A receptor function has been
explored earlier. Thus, depletion of cholesterol from native hippocampal membranes reduces
5-HT1A receptor functions such as ligand binding and G-protein coupling (Pucadyil and
Chattopadhyay 2004a). In addition, replenishment of cholesterol into cholesterol-depleted
membranes restored such functions to a significant extent thus pointing toward the specificity
of the requirement of cholesterol in receptor function. If the ligand binding function of the
5-HT1A receptor is determined by specific interaction between cholesterol and the receptor,
then such interaction would reach saturation at native levels of membrane cholesterol so that
any further enrichment in cholesterol content may not affect ligand binding function of the
receptor. In this paper, we tested this proposal by monitoring the effect of enrichment of
hippocampal membranes with cholesterol on the ligand binding and G-protein coupling of
5-HT1A receptors in such membranes.
Materials and Methods
Materials
BCA, cholesterol, DMPC, MbCD, EDTA, EGTA, MgCl2, MnCl2, Na2HPO4, iodoacetamide,
PMSF, 5-HT, p-MPPI, sucrose, polyethylenimine, sodium azide and Tris were obtained from
Sigma Chemical Co. (St. Louis, MO, USA). GTP-c-S was from Roche Applied Science
(Mannheim, Germany). BCA reagent kit for protein estimation was from Pierce (Rockford, IL,
USA). Amplex Red cholesterol assay kit was from Molecular Probes (Eugene, OR, USA).
[3H]8-OH-DPAT (sp. activity = 135.0 Ci/mmol) and [3H]p-MPPF (sp. activity = 70.5 Ci/
mmol) were purchased from DuPont New England Nuclear (Boston, MA, USA). GF/B glass
microfiber filters were from Whatman International (Kent, UK). All other chemicals used were
of the highest purity available. Water was purified through a Millipore (Bedford, MA, USA)
Milli-Q system and used throughout. Fresh bovine brains were obtained from a local
slaughterhouse within 10 min of death and the hippocampal region was carefully dissected out.
The hippocampi were immediately flash frozen in liquid nitrogen and stored at )70C till
further use.
Preparation of Native Hippocampal Membranes
Native hippocampal membranes were prepared as described previously (Harikumar and
Chattopadhyay 1998). Briefly, bovine hippocampal tissue (~100 g) was homogenized as 10%
(w/v) in a polytron homogenizer in buffer A (2.5 mM Tris, 0.32 M sucrose, 5 mM EDTA,
5 mM EGTA, 0.02% sodium azide, 0.24 mM PMSF, 10 mM iodoacetamide, pH 7.4). The
homogenate was centrifuged at 900g for 10 min at 4C. The resultant supernatant was filtered
through four layers of cheesecloth and centrifuged at 50,000g for 20 min at 4C. The pellet
obtained was suspended in 10 vol. of buffer B (50 mM Tris, 1 mM EDTA, 0.24 mM PMSF,
10 mM iodoacetamide, pH 7.4) using a hand-held Dounce homogenizer and centrifuged at
50,000g for 20 min at 4C. This procedure was repeated until the supernatant was clear. The
final pellet (native membranes) was suspended in a minimum volume of buffer C (50 mM Tris,
pH 7.4), homogenized using a hand-held Dounce homogenizer, flash frozen in liquid nitrogen
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and stored at )70C. Protein concentration was assayed using the BCA assay kit (Smith et al.
1985).
Cholesterol Enrichment of Native Membranes
Native hippocampal membranes were enriched with cholesterol using a water soluble cho-
lesterol-MbCD complex prepared as described previously (Pucadyil and Chattopadhyay
2004a), with a few modifications. Stock solutions of the cholesterol-MbCD complex (typically
containing 2:20 and 4:30 mM cholesterol:MbCD) were prepared by dissolving the required
amounts of cholesterol and MbCD in buffer C by constant shaking at room temperature
(25C). Stock solutions were freshly prepared before each experiment. Native membranes
were incubated with the cholesterol-MbCD complex (final concentration being either 1:10 or
2:15 mM of cholesterol:MbCD) at a protein concentration of 2 mg/ml in buffer C for 1 h at
room temperature (25C) under constant shaking. Membranes were then spun down at 50,000g
for 10 min at 4C, washed once with buffer C and resuspended in the same buffer. Cholesterol
content in membranes was estimated using the Amplex Red cholesterol assay kit (Amundson
and Zhou 1999).
Estimation of Inorganic Phosphate
Concentration of lipid phosphate was determined subsequent to total digestion by perchloric
acid (McClare 1971) using Na2HPO4 as standard. DMPC was used as an internal standard to
assess lipid digestion. Samples without perchloric acid digestion produced negligible readings.
Radioligand Binding Assays
Receptor binding assays were carried out as described earlier (Kalipatnapu and Chattopadhyay
2004) with some modifications. Briefly, tubes in duplicate with 0.5 mg protein in a total
volume of 1 ml of buffer D (50 mM Tris, 1 mM EDTA, 10 mM MgCl2, 5 mM MnCl2, pH
7.4) for agonist binding studies, or in 1 ml of buffer E (50 mM Tris, 1 mM EDTA, pH 7.4) for
antagonist binding assays were used. Tubes were incubated with the radiolabeled agonist
[3H]8-OH-DPAT (final concentration in assay tube being 0.29 nM) or antagonist [3H]p-MPPF
(final concentration in assay tube being 0.5 nM) for 1 h at room temperature (25 C). Non-
specific binding was determined by performing the assay either in the presence of 10 lM
serotonin (for agonist binding assays) or in the presence of 10 lM p-MPPI (for antagonist
binding assays). The binding reaction was terminated by rapid filtration under vacuum in a
Brandel cell harvester (Gaithersburg, MD, USA) through Whatman GF/B 2.5 cm diameter
glass microfiber filters (1.0 lm pore size) which were presoaked in 0.15% (w/v) polyethy-
lenimine for 1 h (Bruns et al. 1983). Filters were then washed 3 times with 3 ml of cold water
(4C), dried and the retained radioactivity was measured in a Packard Tri-Carb 1500 liquid
scintillation counter using 5 ml of scintillation fluid.
GTP-c-S Sensitivity Assay
Agonist binding assays were carried out as described above in the presence of varying con-
centrations of GTP-c-S as described previously (Harikumar and Chattopadhyay 1999). The
concentrations of GTP-c-S leading to 50% inhibition of specific agonist binding (IC50) were
calculated by non-linear regression fitting of the data to a four parameter logistic function
(Higashijima et al. 1987):
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B ¼ a½1 þ ðx=IÞs1 þ b ð1Þ
where, B is the specific binding of the agonist normalized to control binding (in the absence of
GTP-c-S), x denotes concentration of GTP-c-S, a is the range (ymax)ymin) of the fitted curve on
the ordinate (y-axis), I is the IC50 concentration, b is the background of the fitted curve (ymin)
and s is the slope factor.
Results and Discussion
Native hippocampal membranes represent a relatively enriched natural source for the
G-protein coupled serotonin1A (5-HT1A) receptor (Pucadyil et al. 2005a; Kalipatnapu and
Chattopadhyay 2005). These membranes were enriched in cholesterol content using the water
soluble cholesterol:MbCD complex. Such a complex has earlier been reported to efficiently
catalyze cholesterol replenishment of cholesterol-depleted membranes (Pucadyil and Chatto-
padhyay 2004a) and enrichment of CHAPS-solubilized hippocampal membranes with cho-
lesterol (Chattopadhyay et al. 2005). As shown in Fig. 1, treatment of native hippocampal
membranes with increasing concentrations of cholesterol complexed with MbCD results in a
progressive increase in the cholesterol content. Thus, treatment of membranes with 1:10 and
2:15 mM of cholesterol:MbCD complex increases the membrane cholesterol content by ~33
and 38%, respectively. Importantly, the phospholipid content of membranes remained unal-
tered after this treatment (Fig. 1). The cholesterol to phospholipid ratio we observe in native
membranes is ~0.49 (mol/mol), similar to what we have reported earlier (Pucadyil and
Chattopadhyay 2004b). Treatment of native membranes with 1:10 and 2:15 mM of choles-
terol:MbCD complex increases this ratio to ~0.67 and 0.78, respectively.
We monitored the effect of such enrichment in the cholesterol content of hippocampal
membranes on the ligand binding and G-protein coupling of 5-HT1A receptors. The agonist
8-OH-DPAT and antagonist p-MPPF ligands have earlier been well characterized to bind the
5-HT1A receptor with high affinity and specificity (Arvidsson et al. 1981; Gozlan et al. 1983;
Kung et al. 1994; Barr and Manning 1997). Importantly, radioligand binding analyses with
such ligands have earlier provided information on 5-HT1A receptor properties such as the
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proportion of receptors coupled to G-proteins while it exists in a native membrane
environment (Harikumar and Chattopadhyay 1999; Javadekar-Subhedar and Chattopadhyay
2004). Figure 2 shows the specific agonist [3H]8-OH-DPAT and antagonist [3H]p-MPPF
binding to 5-HT1A receptors in cholesterol-enriched membranes. As is apparent from the
figure, enrichment of cholesterol by ~38% results in a small (20%) reduction in specific
binding of the agonist [3H]8-OH-DPAT to the 5-HT1A receptor with no significant effect on
the specific binding of the antagonist [3H]p-MPPF.
The 5-HT1A receptor is negatively coupled to adenylate cyclase through pertussis toxin-
sensitive G-proteins (Emerit et al. 1990). Sensitivity of specific agonist [3H]8-OH-DPAT
binding to guanine nucleotides and hence the G-protein coupling status of the receptor can be
monitored by performing agonist binding assays in the presence of GTP-c-S, a non-hydro-
lyzable analogue of GTP (Harikumar and Chattopadhyay 1999). Thus, the presence of GTP-c-
S induces transition of the receptor from a high affinity to a low affinity state. Figure 3 shows
the inhibition of specific [3H]8-OH-DPAT binding to the 5-HT1A receptor in presence of GTP-
c-S in a characteristic concentration-dependent manner in native and cholesterol-enriched
membranes. The half maximal inhibition concentration (IC50) value for inhibition of specific
[3H]8-OH-DPAT binding by GTP-c-S is ~63 nM in native membranes, similar to what we
reported earlier (Harikumar and Chattopadhyay 1999; Kalipatnapu and Chattopadhyay 2004;
Pucadyil and Chattopadhyay 2004a). However, the inhibition curve for the cholesterol-
enriched membranes exhibits no significant change in the IC50 value (~45 nM). This indicates
that the sensitivity of specific agonist binding to GTP-c-S is similar in native and cholesterol-
enriched membranes indicating that the G-protein coupling of the receptor is not affected upon
cholesterol enrichment. It must be mentioned here that G-protein coupling of the 5-HT1A
receptor is significantly compromised upon depletion of cholesterol from hippocampal
membranes, with the GTP-c-S sensitivity of agonist binding displaying a ~2.5 fold shift toward
higher concentrations of GTP-c-S in cholesterol-depleted membranes (Pucadyil and Chatto-
padhyay 2004a).
The lack of any significant effect of cholesterol enrichment on the 5-HT1A receptor function
(ligand binding and G-protein coupling) is surprising considering earlier studies that have
assessed the modulatory role of cholesterol on membrane protein function. Such studies have
indicated that membrane proteins show optimal function in native membranes containing
natural levels of cholesterol. Thus, the GABAA receptor functions most efficiently in native
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hippocampal membranes containing natural levels of cholesterol (Sooksawate and Simmonds
1998, 2001), with an increase or decrease in the cholesterol level leading to reduction in
receptor function. These results have been interpreted to be due to a specific requirement of
cholesterol at native levels to maintain optimal GABAA receptor function possibly through a
specific cholesterol–receptor interaction, while the reduction in function due to cholesterol
enrichment being due to an alteration in membrane physical properties.
Our results suggest that the 5-HT1A receptor ligand binding remains unaltered upon cho-
lesterol enrichment of hippocampal membranes. Since the enrichment of cholesterol does not
significantly affect the 5-HT1A receptor ligand binding whereas cholesterol depletion reduces
receptor function (Pucadyil and Chattopadhyay 2004a), it appears that the concentration of
cholesterol in native membranes is sufficient for proper receptor function. We have earlier
shown that oxidation of membrane cholesterol to cholestenone results in a marked reduction in
the 5-HT1A receptor ligand binding function (Pucadyil et al. 2005b). Interestingly, while
cholesterol oxidation reduces the functionality of cholesterol, it does not dramatically perturb
the bulk membrane physical properties as measured by fluorescence polarization of mem-
brane-embedded probes. Thus, a reduction in the 5-HT1A receptor function observed under
such conditions possibly suggests the presence of a specific cholesterol–receptor interaction
that supports ligand binding activity. If the cholesterol concentration present in native mem-
branes is sufficient to completely fulfill such a specific cholesterol–receptor interaction, then
further enrichment of cholesterol would bear no functional consequence to receptor function.
This could perhaps explain our results on the relative insensitivity of ligand binding of 5-HT1A
receptors to cholesterol-enrichment. In summary, our present results provide new information
on the effect of cholesterol enrichment on the 5-HT1A receptor function in hippocampal
membranes. In a broader context, these results are relevant in understanding the role of
the membrane lipid environment on the functioning of G-protein coupled transmembrane
receptors in general.
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